Developments of polo-like kinase 1 (Plk1) inhibitors as anti-cancer agents

S Li, Y Zhang, W Xu - Mini reviews in medicinal chemistry, 2013 - ingentaconnect.com
Polo-like kinases (Plks) are a family of serine/threonine kinases with a highly conserved N-
terminal Ser/Thr kinase catalytic domain and a C-terminal region that play crucial roles in …

Elucidation of the inhibitory potential of flavonoids against PKP1 protein in non-small cell lung cancer

P Pandey, F Khan, P Chauhan… - Cellular and Molecular …, 2022 - cellmolbiol.org
PKP1 has been crucially involved in enhancing the MYC translation leading to lung
carcinogenesis via evading numerous tumour-suppressing checkpoint systems. Plakophilin …

Design, synthesis and biological evaluation of novel pteridinone derivatives possessing a hydrazone moiety as potent PLK1 inhibitors

Z Li, L Xu, L Zhu, Y Zhao, T Hu, B Yin, Y Liu… - Bioorganic & Medicinal …, 2020 - Elsevier
A series of novel pteridinone derivatives possessing a hydrazone moiety were designed,
synthesized and evaluated for their biological activity. Most of the synthesized compounds …

The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents

R Laufer, B Forrest, SW Li, Y Liu… - Journal of medicinal …, 2013 - ACS Publications
The family of Polo-like kinases is important in the regulation of mitotic progression; this work
keys on one member, namely Polo-like kinase 4 (PLK4). PLK4 has been identified as a …

Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells

C Zhang, X Sun, Y Ren, Y Lou, J Zhou… - Cancer Biology & …, 2012 - Taylor & Francis
Polo-like kinase 1 (PLK1) is a serine/threonine protein kinase and plays a critical role in
mitosis. PLK1 has also been regarded as a valuable target for cancer treatment, and several …

In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53

J Van den Bossche, C Deben, I De Pauw… - Molecular …, 2019 - Wiley Online Library
Polo‐like kinase 1 (Plk1), a master regulator of mitosis and the DNA damage response, is
considered to be an intriguing target in the research field of mitotic intervention. The …

[HTML][HTML] Target specific inhibition of protein tyrosine kinase in conjunction with cancer and SARS-COV-2 by olive nutraceuticals

A Ghosh, N Mukerjee, B Sharma, A Pant… - Frontiers in …, 2022 - frontiersin.org
The fact that viruses cause human cancer dates back to the early 1980s. By reprogramming
cellular signaling pathways, viruses encoded protein that can regulate altered control of cell …

Computer-aided molecular design of some indolinone derivatives of PLK4 inhibitors as novel anti-proliferative agents

F Shiri, S Rakhshani-morad… - Medicinal Chemistry …, 2016 - Springer
Among the most well-known members of the mitotic protein kinase family are polo-like
kinases. Polo-like kinase 4 as a type of this family is used as a therapeutic target in the …

[HTML][HTML] Cheliensisin A (Chel A) induces apoptosis in human bladder cancer cells by promoting PHLPP2 protein degradation

R Zhang, X Che, J Zhang, Y Li, J Li, X Deng, J Zhu… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract Cheliensisin A (Chel A), a styryl-lactone compound extracted from Goniothalamus
cheliensis, is reported to have significant anti-cancer effects in various cancer cells. Here we …

[HTML][HTML] Dieckol: A brown algal phlorotannin with biological potential

DK Rajan, K Mohan, S Zhang, AR Ganesan - Biomedicine & …, 2021 - Elsevier
Abstract Dieckol [C 36 H 22 O 18], is a naturally occurring phlorotannin found in some brown
algal species. Dieckol is gaining more attention in the scientific community for its potential …